Potential therapeutic interventions might include inhibiting the Wnt/β-catenin signaling pathway or the TGF-β1/Smads signaling pathway, thereby suppressing CFB proliferation, attenuating collagen production, minimizing atrial structural remodeling, and preventing AF-induced cardiac fibrosis and subsequent IHF development. This evidence concerns the gene TGFB1 and atrial fibrillation.